Accelerating Antibody Discovery Using Advanced Flow Cytometry
Duration: 30 minutes
The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this, has been the advancement of technologies which improve the efficiency of antibody discovery. Robust, high-throughput techniques for screening antibody libraries, have led to better quality hits in shorter timescales. In addition, combining several in vitro methods to assess a broad range of antibody parameters, such as Fc function characteristics and target binding, builds a full profile of a candidate molecule and informs pre-clinical studies.
Complete the Form to Access the Webinar
Scientist, AnalyticsSartorius
Kirsty McBain is a Scientist in the BioAnalytics Group of Sartorius, where she is involved in the research and development of novel applications.Kirsty’s efforts are focused on the iQue® Advanced Flow Cytometry Platform where she has supported a number of the immuno-oncology campaigns that are used to exemplify how Sartorius technology can be applied to the drug discovery process. Kirsty obtained a master’s degree in Biochemistry at the University of Bristol before joining Sartorius in 2019.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now